About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 204 record(s)
Req # A-2021-10664
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Servier Canada Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
August 2021
Req # A-2021-10688
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Innovation for Patient Care over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
August 2021
Req # A-2021-10770
All communications between the PMPRB and ISED officials from May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2021
Req # A-2021-12332
Copies of all final IQVIA contracts and accompanying briefing materials, if applicable, for the contracts associated with the following procurement ID numbers: 160005 A3; 160005 A2; 160005 A5; 160005 A6; 160005 A7; 180030; 16NL008 A3; 16NL021 A4; 16NL021 A5; 16NL008 A4; 200051; 210020; 210021; and 200051 A1.Organization: Patented Medicine Prices Review Board Canada
August 2021
Req # A-2021-11082
Copies of all documents presented, and shared with participants related to the symposium organized by the PMPRB with academics during the week of May 31, 2021.Organization: Patented Medicine Prices Review Board Canada
July 2021
Req # A-2021-09955
Copy of the French version of the February 9, 2021 communication plan titled "Modern and Proactive Communications Strategy".Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11663
A copy of the release package that was disclosed in response to access to information request file number A-2021-007891.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11666
A copy of the PMPRB's 6-page Communication Plan, "Modern and Proactive Communications Strategy", dated February 9, 2021 as previously disclosed in a release package in response to an access to information request.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11668
Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-07238
Copies of all information, data, document, or correspondence concerning the PMPRB's classification of the following drug products: NOVORAPID and FIASP, each a product of NOVO NORDISK CANADA INC, a corporation located at 101-2476 Argentia Road, Mississauga, Ontario, Canada L5N 6M1, including but not limited to classifications based on drug product line extensions, similar chemical entities, comparable dosages, or a reasonable relationship between the two drugs, as well as any other analysis, comments, or information related to the classification of these two drugs.Organization: Patented Medicine Prices Review Board Canada
May 2021